that's true, i was thinking to average out but possibility of bad news on fda submission might get sp to fall significantly... so not worth risking capital. new management is not sharing any information and the way they ditched TGA application before formal meeting makes this management poor performer.. IMO.
OSL Price at posting:
5.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)